Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PUT
Ball Corp
BALL
$17.1B
| $1.28M | 0.03% |
+25,100
| New | +$1.3M |
|
927
Modine Manufacturing
MOD
$10B
| $1.28M | 0.03% |
+64,574
| New | +$1.2M |
|
928
Oscar Health
OSCR
$9.82B
| $1.28M | 0.03% |
521,226
+251,379
| +93% | +$786K |
|
|
DCT
929
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $1.28M | 0.03% |
106,334
+56,334
| +113% | +$646K |
|
930
Old National Bancorp
ONB
$9.86B
| $1.28M | 0.03% |
+71,172
| New | +$1.31M |
|
931
CALL
Chubb
CB
$133B
| $1.28M | 0.03% |
5,800
+1,200
| +26% | +$250K |
|
|
EONR
932
EON Resources
EONR
$24.2M
| $1.28M | 0.03% |
125,000
| – | – |
|
|
DENN
933
DELISTED
Denny's
DENN
| $1.28M | 0.03% |
+138,679
| New | +$1.5M |
|
934
Xeris Biopharma Holdings
XERS
$1.59B
| $1.28M | 0.03% |
960,111
| – | – |
|
935
Quaker Houghton
KWR
$2.79B
| $1.28M | 0.03% |
7,644
-1,427
| -16% | -$240K |
|
|
VTLE
936
DELISTED
Vital Energy
VTLE
| $1.28M | 0.03% |
+24,806
| New | +$1.53M |
|
937
CALL
CarMax
KMX
$8.91B
| $1.27M | 0.03% |
20,900
+17,100
| +450% | +$1.1M |
|
938
ASML
ASML
$668B
| $1.27M | 0.03% |
2,328
-3,504
| -60% | -$1.84M |
|
939
Dick's Sporting Goods
DKS
$16.1B
| $1.27M | 0.03% |
10,528
+4,311
| +69% | +$486K |
|
940
PUT
General Dynamics
GD
$104B
| $1.27M | 0.03% |
+5,100
| New | +$1.24M |
|
941
PUT
Idexx Laboratories
IDXX
$44.1B
| $1.27M | 0.03% |
3,100
+500
| +19% | +$194K |
|
|
AKRO
942
DELISTED
Akero Therapeutics
AKRO
| $1.26M | 0.02% |
22,998
+10,852
| +89% | +$465K |
|
943
Expedia Group
EXPE
$40.7B
| $1.26M | 0.02% |
+14,380
| New | +$1.36M |
|
944
Rithm Capital
RITM
$5.72B
| $1.26M | 0.02% |
+154,076
| New | +$1.29M |
|
945
Skyworks Solutions
SWKS
$10.1B
| $1.26M | 0.02% |
+13,817
| New | +$1.24M |
|
946
PUT
Marvell Technology
MRVL
$206B
| $1.25M | 0.02% |
+33,800
| New | +$1.38M |
|
947
CALL
Chipotle Mexican Grill
CMG
$48.1B
| $1.25M | 0.02% |
45,000
-45,000
| -50% | -$1.34M |
|
948
PUT
Ally Financial
ALLY
$12.9B
| $1.25M | 0.02% |
51,100
+20,400
| +66% | +$543K |
|
949
Enviri
NVRI
$595M
| $1.25M | 0.02% |
198,414
+15
| +0% | +$89 |
|
950
Gates Industrial Corp
GTES
$6.59B
| $1.25M | 0.02% |
109,284
-78,526
| -42% | -$866K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.